Filing Details
- Accession Number:
- 0001181431-12-033370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-30 15:31:31
- Reporting Period:
- 2012-05-29
- Filing Date:
- 2012-05-30
- Accepted Time:
- 2012-05-30 15:31:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 919745 | Dara Biosciences Inc. | DARA | Pharmaceutical Preparations (2834) | 043216862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428764 | David Drutz | C/O Dara Biosciences, Inc. 8601 Six Forks Road, Suite 160 Raleigh NC 27615 | Ceo And Cmo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-29 | 25,000 | $0.90 | 28,073 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
